INNOTEG Controlled Substance Reference Standards – Schedule II Psychotropic Substances
| Brand | INNOTEG |
|---|---|
| Origin | Guangdong, China |
| Supplier Type | Authorized Distributor |
| Product Category | Domestic Standard Reference Materials |
| Schedule Classification | China NMPA Schedule II Psychotropic Substances |
| Pricing | Available Upon Request |
Overview
The INNOTEG Schedule II Psychotropic Substance Reference Standards are high-purity certified reference materials (CRMs) designed for forensic toxicology, pharmaceutical quality control, clinical laboratory validation, and regulatory compliance testing. These standards conform to the Chinese National Medical Products Administration (NMPA) classification of psychotropic substances under Schedule II — compounds subject to strict control due to their potential for abuse, dependence liability, and defined therapeutic utility. Each batch is traceable to national metrological standards, with certificate of analysis (CoA) including purity ≥98.5% (by HPLC-UV), identity confirmation via FTIR and NMR, water content (Karl Fischer), residual solvents (GC), and heavy metal limits (ICP-MS). The series supports method development and verification for liquid chromatography–tandem mass spectrometry (LC-MS/MS), gas chromatography–mass spectrometry (GC-MS), and immunoassay platforms used in anti-doping labs, forensic science institutes, and hospital toxicology departments.
Key Features
- Comprehensive coverage of 40+ Schedule II psychotropic analytes, grouped by pharmacological class: antipsychotics (e.g., olanzapine, chlorpromazine, clozapine), antidepressants (e.g., amitriptyline, imipramine hydrochloride, nortriptyline), anxiolytics/hypnotics (e.g., zolpidem, diazepam, lorazepam, alprazolam), stimulants (e.g., caffeine, amphetamine analogues), opioids (e.g., oxycodone, morphine, fentanyl analogues), and dissociative agents (e.g., ketamine, THC, CBD).
- Individually sealed, amber glass vials under inert nitrogen atmosphere; certified shelf life of 24 months when stored at –20 °C.
- Batch-specific CoA includes uncertainty budget per ISO/IEC 17025:2017 requirements and alignment with CNAS-CL04 guidelines for reference material producers.
- Available in multiple concentration formats: neat solids (10 mg/vial), solution standards (1.0 mg/mL in acetonitrile or methanol), and custom-dilution sets for calibration curve preparation.
Sample Compatibility & Compliance
These reference standards are validated for use in human biological matrices (urine, blood, oral fluid) and pharmaceutical dosage forms (tablets, injectables, transdermal patches). They meet analytical requirements specified in GB/T 29637–2013 (Determination of Psychotropic Substances in Biological Samples), SFDA Guidance on Bioanalytical Method Validation (2020), and international harmonized protocols including EMA CHMP Guideline on Bioanalytical Method Validation (2022). All materials are manufactured in facilities compliant with ISO 9001:2015 and ISO/IEC 17025:2017. Documentation supports audit readiness for GLP, GCP, and CNAS-accredited laboratory inspections. No export license required for domestic distribution within mainland China; international shipment subject to IATA Dangerous Goods Regulations (Class 6.1) and local controlled substance import permits.
Software & Data Management
Each CRM batch is assigned a unique QR-coded label linked to a secure online portal for digital CoA access, stability data logs, and lot-specific impurity profiles. Integration with LIMS systems (e.g., Thermo Fisher SampleManager, LabVantage) is supported via CSV and ASTM E1702-compliant XML export. Audit trails comply with NMPA Annex 14 (Computerized Systems in Pharmaceutical Quality Control) and include full electronic signature capability aligned with FDA 21 CFR Part 11 requirements for regulated environments.
Applications
- Forensic toxicology screening and confirmatory analysis in public security laboratories and judicial appraisal centers.
- Pharmaceutical QC release testing of psychotropic APIs and finished products against ChP 2020 monographs.
- Method validation for bioequivalence studies involving CNS-active drugs under NMPA Drug Clinical Trial Registration requirements.
- Calibration of GC-MS and LC-MS/MS instruments used in anti-doping control laboratories accredited to ISO/IEC 17025.
- Training and proficiency testing for clinical laboratory personnel conducting therapeutic drug monitoring (TDM) of antidepressants and benzodiazepines.
FAQ
Are these reference standards suitable for quantitative LC-MS/MS analysis?
Yes — each standard is qualified for quantitation with ≤2.5% relative expanded uncertainty (k=2) at typical working concentrations (1–1000 ng/mL in plasma matrix).
Do you provide stability data under accelerated conditions?
Yes — real-time and ICH Q1A(R2)-compliant accelerated stability data (40 °C/75% RH) are included in the CoA for all solid and solution forms.
Can I request custom mixtures of multiple Schedule II analytes?
Yes — custom multi-analyte calibration kits are available upon technical review and compliance assessment per NMPA administrative regulations.
Is documentation provided in English for international regulatory submissions?
Yes — bilingual CoA (Chinese/English), SDS, and method suitability reports are issued for export-supported batches.
What is the minimum order quantity for research-use-only (RUO) distribution?
The standard RUO minimum is one vial per analyte; bulk pricing applies for orders exceeding 10 analytes or ≥50 vials total.
